EVERSANA · 14 hours ago
Intern, EVERSANA Management Consulting (June 2026 Start, 10-week Program)
New York, NY
Internship
Onsite
Intern
Start in 2026 SummerEVERSANA is a global leader in commercialization services for the life sciences industry, dedicated to creating a healthier world. They are seeking interns for their Management Consulting program, where interns will support critical strategic questions within the biopharmaceutical space, engage in research, and contribute to client deliverables.
Pharmaceutical
Responsibilities
Supporting targeted secondary research (e.g., desk risk, secondary data analysis) and primary research (e.g., interviews with key opinion leaders / insurance payers)
Synthesizing research insights to develop logical and effective client recommendations
Developing high-quality client communications and deliverables (e.g., PowerPoint slides, Excel models)
Communicating verbal and written information in logical, clear, and concise fashion
Contributing to the development of the firm’s capabilities and infrastructure
Supporting the development of a high-performance culture
Qualification
Required
Motivated individuals enrolled in a full-time MBA or PhD program with an interest in Life Science Consulting and/or the biopharmaceutical industry
A strong passion for—and understanding of dynamics and issues in—the pharma and biotech industries
Strong analytical, problem-solving, and communication skills
Proficiency in Microsoft Excel and PowerPoint
Company
EVERSANA
EVERSANA is the provider of global services to the life science industry.
Founded in 2018
5001-10000 employees
H1B Sponsorship
EVERSANA has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (28)
2024 (9)
2023 (24)
2022 (9)
2021 (9)
2020 (7)
Funding
Current Stage
Late StageTotal Funding
unknown2018-10-01Private Equity
Leadership Team
Mark Thierer
Chief Executive Officer
Suzanne Greenwood
Chief Commercial Officer, Oncology
Recent News
2026-01-05
Company data provided by crunchbase